Siemens ELF test gets FDA breakthrough device designation  

Create PDF

The test directly measures liver fibrosis and is composed of three direct biomarkers—hyaluronic acid, procollagen III amino-terminal peptide, and tissue inhibitor of metalloproteinase 1 in a proprietary algorithm. Prognostic risk assessments using the test help identify patients who could benefit from additional examinations.